Medistim ASA (MEDI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medistim ASA (MEDI) has a cash flow conversion efficiency ratio of 0.098x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr37.65 Million ≈ $3.96 Million USD) by net assets (Nkr383.81 Million ≈ $40.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Medistim ASA (MEDI) total market value for the company's overall valuation and market capitalisation.
Medistim ASA - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Medistim ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medistim ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medistim ASA ranked by their cash flow conversion efficiency. Explore MEDI cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Anhui Zhongyuan New Materials Co Ltd
SHG:603527
|
-0.130x |
|
Youdao Inc
NYSE:DAO
|
0.389x |
|
Prisma Properties
ST:PRISMA
|
0.016x |
|
ATN International Inc
NASDAQ:ATNI
|
0.033x |
|
Shanghai Xuerong Bio-Technology Co Ltd
SHE:300511
|
-0.053x |
|
Rapid7 Inc
NASDAQ:RPD
|
0.228x |
|
Xiamen R&T Plumbing Technology Co Ltd
SHE:002790
|
0.021x |
|
Chorus Aviation Inc
TO:CHR
|
0.127x |
Annual Cash Flow Conversion Efficiency for Medistim ASA (2004–2024)
The table below shows the annual cash flow conversion efficiency of Medistim ASA from 2004 to 2024. View latest Medistim ASA stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Nkr436.61 Million ≈ $45.94 Million |
Nkr143.10 Million ≈ $15.06 Million |
0.328x | +15.23% |
| 2023-12-31 | Nkr397.94 Million ≈ $41.87 Million |
Nkr113.19 Million ≈ $11.91 Million |
0.284x | -8.70% |
| 2022-12-31 | Nkr367.69 Million ≈ $38.69 Million |
Nkr114.56 Million ≈ $12.05 Million |
0.312x | -25.59% |
| 2021-12-31 | Nkr306.05 Million ≈ $32.21 Million |
Nkr128.14 Million ≈ $13.48 Million |
0.419x | +45.06% |
| 2020-12-31 | Nkr256.85 Million ≈ $27.03 Million |
Nkr74.13 Million ≈ $7.80 Million |
0.289x | -14.95% |
| 2019-12-31 | Nkr236.86 Million ≈ $24.92 Million |
Nkr80.38 Million ≈ $8.46 Million |
0.339x | +25.73% |
| 2018-12-31 | Nkr206.71 Million ≈ $21.75 Million |
Nkr55.79 Million ≈ $5.87 Million |
0.270x | -17.83% |
| 2017-12-31 | Nkr182.98 Million ≈ $19.26 Million |
Nkr60.10 Million ≈ $6.32 Million |
0.328x | +79.69% |
| 2016-12-31 | Nkr166.70 Million ≈ $17.54 Million |
Nkr30.47 Million ≈ $3.21 Million |
0.183x | -36.08% |
| 2015-12-31 | Nkr156.16 Million ≈ $16.43 Million |
Nkr44.66 Million ≈ $4.70 Million |
0.286x | -18.72% |
| 2014-12-31 | Nkr139.10 Million ≈ $14.64 Million |
Nkr48.94 Million ≈ $5.15 Million |
0.352x | +64.32% |
| 2013-12-31 | Nkr121.64 Million ≈ $12.80 Million |
Nkr26.04 Million ≈ $2.74 Million |
0.214x | -6.06% |
| 2012-12-31 | Nkr115.17 Million ≈ $12.12 Million |
Nkr26.25 Million ≈ $2.76 Million |
0.228x | -1.22% |
| 2011-12-31 | Nkr106.89 Million ≈ $11.25 Million |
Nkr24.66 Million ≈ $2.60 Million |
0.231x | -33.24% |
| 2010-12-31 | Nkr107.83 Million ≈ $11.35 Million |
Nkr37.27 Million ≈ $3.92 Million |
0.346x | +12.06% |
| 2009-12-31 | Nkr106.29 Million ≈ $11.19 Million |
Nkr32.78 Million ≈ $3.45 Million |
0.308x | +10.02% |
| 2008-12-31 | Nkr95.46 Million ≈ $10.05 Million |
Nkr26.76 Million ≈ $2.82 Million |
0.280x | +26.46% |
| 2007-12-31 | Nkr93.83 Million ≈ $9.87 Million |
Nkr20.80 Million ≈ $2.19 Million |
0.222x | -5.17% |
| 2006-12-31 | Nkr74.06 Million ≈ $7.79 Million |
Nkr17.31 Million ≈ $1.82 Million |
0.234x | +5.83% |
| 2005-12-31 | Nkr67.41 Million ≈ $7.09 Million |
Nkr14.89 Million ≈ $1.57 Million |
0.221x | +152.67% |
| 2004-12-31 | Nkr61.71 Million ≈ $6.49 Million |
Nkr5.39 Million ≈ $567.71K |
0.087x | -- |
About Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in… Read more